NCC MEDICAL GROUP is recognized as a leading innovator in neuro-diagnostic and neuro-monitoring technologies. As a nationally recognized “Little Giant” SRDI enterprise, the company has built a strong reputation for specialized research, refined manufacturing capabilities, differentiated technologies, and continuous innovation within the medical device industry.
Founded in 1997, NCC has developed into a comprehensive medical technology organization integrating research, manufacturing, global distribution, and clinical education. The company’s research and manufacturing headquarters are located in Shanghai, China, one of the world’s most dynamic medical technology hubs. From this center, NCC conducts advanced neurophysiology research and precision manufacturing of medical devices and consumables.
To support global operations, NCC has also established a quality management and compliance center in Singapore. This strategic hub ensures that all NCC products meet international regulatory standards and global market requirements. By combining China’s manufacturing strength with Singapore’s regulatory expertise, NCC maintains strict quality control across its entire product portfolio.
The company’s core expertise covers several key areas including IONM (Intraoperative Neuromonitoring), EEG, PSG, EMG, and medical consumables. Through continuous research and development, NCC has introduced a range of innovative clinical solutions that help hospitals improve surgical safety and diagnostic accuracy. Products such as neuromonitoring systems, electrodes, and related consumables are widely used in operating rooms and neurophysiology laboratories around the world.
A key factor behind NCC’s growth is its commitment to technological innovation. As an SRDI enterprise, NCC has developed numerous patented technologies that support high-precision neural monitoring and signal acquisition. These innovations allow clinicians to obtain clearer neurophysiological data, which plays a critical role in protecting neural structures during complex surgeries.
Beyond product development, NCC places strong emphasis on clinical education and professional support. The company operates 31 training and technical support centers across China, where clinicians and biomedical engineers receive specialized training in EEG, EMG, and IONM technologies. Through the NCC Innovation Academy, medical professionals can participate in continuous education programs designed to improve surgical outcomes and diagnostic accuracy.
To further enhance clinical services, NCC has established the NeuGuard Service Platform, which provides hospitals with technical assistance, training programs, and operational support. This integrated service model ensures that healthcare providers can implement NCC technologies effectively within their clinical workflows.
NCC’s global footprint continues to expand through a comprehensive distribution network. Today, the company’s solutions are used in over 50 countries and more than 5,000 hospitals across China. International markets include Southeast Asia, Australia, Europe, the Americas, and Africa. From leading teaching hospitals to regional medical centers, NCC products are recognized for their reliability, accuracy, and clinical value.
The company’s mission—“Safeguarding Life and Health”—reflects its long-term commitment to improving patient care. By advancing safer surgical technologies and precise neurodiagnostic tools, NCC aims to help healthcare providers deliver better outcomes for patients worldwide.
Looking ahead, NCC continues to invest in research, manufacturing capacity, and global partnerships. By strengthening its international distributor network and expanding training programs, the company is committed to bringing advanced neurophysiology solutions to healthcare systems around the world.
Copyright © NCC Medical Co., Ltd. - Privacy policy